The Center for Public Integrity
Home
About the Center
ICIJ
Donate
Investigations by email
Politics
Accountability
Health
Environment
National Security
Juvenile Justice
Pharmacology - news and investigations - Page 2
Surrogates for their agenda
By
Alexander Cohen
July 7, 2005
How the drug industry uses non-profits to push its interests
Related to this story
More big money from pharmaceutical lobby in 2008
By
Mary Beth Lombardo
July 11, 2008
Drug makers' dime funds Congressional travel
By
Robert Brodsky
August 30, 2006
Deep pockets contribute to success
By
M. Asif Ismail
April 6, 2006
FDA staff travels on drug industry dollars
By
Alexander Cohen
March 30, 2006
Drug industry influence timeline
By
The Center for Public Integrity
July 7, 2005
What the pharmaceutical industry has gotten on its political investment
Related to this story
FDA staff travels on drug industry dollars
By
Alexander Cohen
March 30, 2006
A record year for the pharmaceutical lobby in '07
By
M. Asif Ismail
June 24, 2008
States see importation as solution to high drug costs
By
Victoria Kreha
April 6, 2006
Most drug trial results analyzed by FDA hidden from view
By
Naseem Miller
May 14, 2010
PhRMA's envoys
By
M. Asif Ismail
January 18, 2005
Former ambassador lobbies Canadians on drug imports to U.S.
Related to this story
Spending on lobbying thrives
By
M. Asif Ismail
April 1, 2007
Prescription for power
By
M. Asif Ismail
April 28, 2005
Commentary: Changing Washington: The hard part
By
Bill Buzenberg
March 24, 2009
Drug lobby second to none
By
M. Asif Ismail
July 7, 2005
Advertisement
FDA failure to ensure drug safety
By
The Center for Public Integrity
December 10, 2008
Vioxx dangers raise questions about FDA's ability to monitor drugs
Related to this story
Prescription for power
By
M. Asif Ismail
April 28, 2005
FDA: A shell of its former self
By
M. Asif Ismail
July 7, 2005
Inkling of concern: Chemicals in tattoo inks face scrutiny
By
Brett Israel
August 31, 2011
Dust reforms stymied by years of inaction
By
Ken Ward Jr.
July 8, 2012
Prescription for power
By
M. Asif Ismail
April 28, 2005
Drug makers' lobbying army ensures their legislative dominance
Related to this story
Senator seeks deadline for Medicare to prevent prescription drug fraud
By
Joe Eaton
August 5, 2010
OPINION: Big Pharma's stranglehold on Washington
By
Wendell Potter
February 11, 2013
PhRMA's envoys
By
M. Asif Ismail
January 18, 2005
OPINION: drug firms say no to rebates, despite billions in new revenue from Part D
By
Wendell Potter
February 18, 2013
Government orders Columbia to tell patients 'true nature' of drug study
By
Jeanne Lenzer
and
Shannon Brownlee
October 7, 2009
Officials say research may have caused harm to people who had heart surgery
Related to this story
Major gaps in oversight of human medical research
By
Jeanne Lenzer
and
Shannon Brownlee
October 28, 2009
FDA staff travels on drug industry dollars
By
Alexander Cohen
March 30, 2006
Drug industry influence timeline
By
The Center for Public Integrity
July 7, 2005
Most drug trial results analyzed by FDA hidden from view
By
Naseem Miller
May 14, 2010
Advertisement
Major gaps in oversight of human medical research
By
Jeanne Lenzer
and
Shannon Brownlee
October 28, 2009
Columbia Hospital case a cautionary tale
Related to this story
Government orders Columbia to tell patients 'true nature' of drug study
By
Jeanne Lenzer
and
Shannon Brownlee
October 7, 2009
FDA staff travels on drug industry dollars
By
Alexander Cohen
March 30, 2006
Drug industry influence timeline
By
The Center for Public Integrity
July 7, 2005
Most drug trial results analyzed by FDA hidden from view
By
Naseem Miller
May 14, 2010
Drug lobby donation went to pro-Democratic nonprofit
By
Michael Beckel
November 30, 2012
Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.
Related to this story
PhRMA's envoys
By
M. Asif Ismail
January 18, 2005
A record year for the pharmaceutical lobby in '07
By
M. Asif Ismail
June 24, 2008
Spending on lobbying thrives
By
M. Asif Ismail
April 1, 2007
OPINION: drug firms say no to rebates, despite billions in new revenue from Part D
By
Wendell Potter
February 18, 2013
OPINION: drug firms say no to rebates, despite billions in new revenue from Part D
By
Wendell Potter
February 18, 2013
Part D brought drug companies billions, but they say the sky is falling
Related to this story
OPINION: Big Pharma's stranglehold on Washington
By
Wendell Potter
February 11, 2013
OPINION: taking advantage of Medicare Advantage
By
Wendell Potter
March 11, 2013
Prescription for power
By
M. Asif Ismail
April 28, 2005
PhRMA's envoys
By
M. Asif Ismail
January 18, 2005
Pages
« first
‹ previous
1
2
Powered by
Calais